Wall Street is projecting earnings will decline year-over-year, while revenue is expected to rise.
Analysts surveyed by FactSet are forecasting adjusted earnings of $1.90 per share and $9.87 billion in revenue.
In 2015, Bloomfield, CT-based Cigna reported adjusted earnings of $2.28 per share on revenue of $9.39 billion for the third quarter.
Separately, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.
The team rates Cigna as a Buy with a ratings score of B. The company's strengths can be seen in multiple areas, such as its revenue growth and largely solid financial position with reasonable debt levels by most measures. The team feels its strengths outweigh the fact that the company has had sub par growth in net income.
You can view the full analysis from the report here: CI